Table 2.
Antibiotic susceptibility for R. gnavus in this and previous cases
|
Antibiotic |
Resistance in this case |
Resistant isolates/total no. of isolates in previous cases |
|---|---|---|
|
Amoxicillin |
nd |
0/2 |
|
Amoxicillin/clavulanate |
nd |
0/2 |
|
Benzylpenicillin |
S |
1/5 |
|
Cefalothin |
nd |
0/1 |
|
Cefotaxime |
nd |
0/2 |
|
Ceftriaxonea |
nd |
0/1 |
|
Clindamycin |
S |
2/6 |
|
Erythromycin |
nd |
1/1 |
|
Gentamicin |
nd |
1/1 |
|
Imipenem |
nd |
0/3 |
|
Levofloxacin |
nd |
2/2 |
|
Lincomycin |
nd |
1/1 |
|
Linezolid |
nd |
½ |
|
Meropenem |
S |
0/2 |
|
Metronidazole |
S |
0/7 |
|
Moxifloxacina |
nd |
3/3 |
|
Piperacillin/tazobactam |
nd |
0/5 |
|
Pristinamycin |
nd |
0/1 |
|
Rifampicin |
nd |
0/2 |
|
Tetracycline |
S |
nd |
|
Ticarcillin/clavulanate |
nd |
0/1 |
|
Tigecyclinea |
nd |
1/4 |
|
Trimethoprim/sulfamethoxazole |
nd |
0/1 |
|
Vancomycin |
nd |
0/7 |
a No breakpoints were found for Gram-positive anaerobes, and the non-species-specific breakpoints were used.
nd: No data, S: susceptible.